577
Participants
Start Date
July 20, 2015
Primary Completion Date
July 11, 2016
Study Completion Date
March 20, 2017
Erenumab
Administered once a month by subcutaneous injection
Placebo
Administered once a month by subcutaneous injection
Research Site, Geneva
Research Site, Biel
Research Site, Glostrup Municipality
Research Site, Ballerup Municipality
Research Site, Bad Zurzach
Research Site, Lugano
Research Site, Vejle
Research Site, Zollikon
Research Site, Aalborg
Research Site, Sankt Gallen
Research Site, Athens
Research Site, Athens
Research Site, Williamsville
Research Site, Santiago de Compostela
Research Site, Athens
Research Site, Philadelphia
Research Site, Baltimore
Research Site, Virginia Beach
Research Site, Winston-Salem
Research Site, Madrid
Research Site, Asheville
Research Site, Mt. Pleasant
Research Site, Atlanta
Research Site, Jacksonville
Research Site, Oviedo
Research Site, Orlando
Research Site, Hollywood
Research Site, Bordeaux
Research Site, Palm Beach Gardens
Research Site, Birmingham
Research Site, Chattanooga
Research Site, Santander
Research Site, Lexington
Research Site, Cincinnati
Research Site, Valencia
Research Site, Valencia
Research Site, Indianapolis
Research Site, Valladolid
Research Site, Ann Arbor
Research Site, Kalamazoo
Research Site, Zaragoza
Research Site, Thessaloniki
Research Site, Gurnee
Research Site, Lenexa
Research Site, Oklahoma City
Research Site, Pringy
Research Site, Paris
Research Site, Paris
Research Site, Dallas
Research Site, Austin
Research Site, Colorado Springs
Research Site, Salt Lake City
Research Site, Phoenix
Research Site, Albuquerque
Research Site, Culver City
Research Site, Santa Monica
Research Site, Long Beach
Research Site, San Diego
Research Site, Walnut Creek
Research Site, Sacramento
Research Site, Seattle
Research Site, Moscow
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Ufa
Research Site, Novosibirsk
Research Site, Fairfield
Research Site, Boston
Research Site, Princeton
Research Site, Warwick
Research Site, Nice
Research Site, Amadora
Research Site, Lisbon
Research Site, Lisbon
Research Site, Torres Vedras
Research Site, Barcelona
Lead Sponsor
Amgen
INDUSTRY